General
Preferred name
VOGLIBOSE
Synonyms
AO 128 ()
Glustat ()
Basen ()
A-71100 ()
Voglibosa ()
AO-128 ()
P&D ID
PD000460
CAS
83480-29-9
Tags
available
drug
Approved by
PMDA
First approval
1994
Drug indication
diabetes mellitus
Diabetic complication
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Voglibose is an orally active alpha-glucosidase inhibitor that prevents the development of colorectal precancerous lesions induced by obesity and diabetes. Voglibose reduces oxidative stress in an inflammatory environment and inhibits the insulin-like growth factor/insulin-like growth factor-1 receptor (IGF/IGF-1R) functional axis[1].
DESCRIPTION Voglibose (Glustat), an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against ??-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia.
DESCRIPTION Orally active alpha-glucosidase inhibitor (Tocriscreen Plus)
DESCRIPTION Orally active α-glucosidase inhibitor (Tocriscreen Total)
DESCRIPTION Voglibose (Glustat), an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia. (TargetMol Bioactive Compound Library)
Compound Sets
20
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
Tocriscreen Plus
Tocriscreen Total
ZINC Tool Compounds
External IDs
88
Properties
(calculated by RDKit )
Molecular Weight
267.13
Hydrogen Bond Acceptors
8
Hydrogen Bond Donors
8
Rotatable Bonds
5
Ring Count
1
Aromatic Ring Count
0
cLogP
-4.49
TPSA
153.64
Fraction CSP3
1.0
Chiral centers
5.0
Largest ring
6.0
QED
0.25
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Enzymes
Target
α-glucosidase
MGAM
Carbohydrate Metabolism
Glycosidase
Member status
member
MOA
alpha-Glucosidase Inhibitors
inhibits digestion and absorption of glucose from intestine
glucosidase inhibitor
Indication
diabetes mellitus, hyperglycemia
Pathway
Metabolism
Metabolic Enzyme/Protease
Therapeutic Class
Hypoglycemic Agents
Source data